{"id":11465,"date":"2025-07-26T17:53:46","date_gmt":"2025-07-26T15:53:46","guid":{"rendered":"https:\/\/valintermed.com\/?p=11465"},"modified":"2025-07-26T17:53:46","modified_gmt":"2025-07-26T15:53:46","slug":"gemoglobin-e-bolezn","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/gemoglobin-and-disease\/","title":{"rendered":"Hemoglobin E Disease"},"content":{"rendered":"
<\/div>\n

Hemoglobin E (HbE) is a form of hemoglobin resulting from a mutation in the HBB gene located on chromosome 11. Hemoglobin E-associated disease is often considered a beta-thalassemia, which involves substitution of amino acids in the globin chains. As a result, the structural and functional form of hemoglobin is altered, which can lead to various hemoglobinopathies, including anemia, enlarged spleen, and other associated conditions. In particular, patients with hemoglobin E may have elements of susceptibility to more serious blood disorders due to impaired oxygen transport and an increased tendency to hemolysis. Proper diagnosis and early intervention are key in the management of hemoglobin E-associated diseases, as they can range from mild to severe.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n